Hiroyuki Ohbayashi

Publication Activity (10 Years)

Years Active: 2018-2021
Publications (10 Years): 4

Top Topics

Chronic Obstructive Pulmonary Disease

Placebo Controlled

Top Venues

Pulmonary therapy

Journal of asthma and allergy

Current medical research and opinion

This page only lists publications with an associated author ORCID identifier.

Publications

Hiroyuki Ohbayashi, Takamitsu Asano, Sahori Kudo, Mitsue Ariga
Comparison of User Satisfaction and Preference with Inhalant Devices Between a Pressurized Metered-Dose Inhaler and Ellipta in Stable Asthma Patients: A Randomized, Crossover Study. Pulmonary therapy 7 (1) (2021)
Soichiro Hozawa, Hiroyuki Ohbayashi, Michiko Tsuchiya, Yu Hara, Laurie A Lee, Takashi Nakayama, Jun Tamaoki, Andrew Fowler, Takanobu Nishi
Safety of Once-Daily Single-Inhaler Triple Therapy with Fluticasone Furoate/Umeclidinium/Vilanterol in Japanese Patients with Asthma: A Long-Term (52-Week) Phase III Open-Label Study. Journal of asthma and allergy 14 (2021)
Yoichi Nakamura, Soichiro Hozawa, Hironori Sagara, Hiroyuki Ohbayashi, Laurie A Lee, Jodie Crawford, Jun Tamaoki, Takanobu Nishi, Andrew Fowler
Efficacy and safety of once-daily, single-inhaler fluticasone furoate/umeclidinium/vilanterol versus fluticasone furoate/vilanterol in Japanese patients with inadequately controlled asthma: the CAPTAIN study. Current medical research and opinion 37 (9) (2021)
Hiroyuki Ohbayashi, Sahori Kudo, Mitsue Ariga
Evaluation of Rapid Onset of Action of ICS/LABA Combination Therapies on Respiratory Function in Asthma Patients: A Single-Center, Open-Label, Randomized, Crossover Trial. Pulmonary therapy 4 (2) (2018)